Anti-CDH17 antibodies and uses thereof

TW202639602APending Publication Date: 2026-10-01LEPU BIOPHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115121355
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-09-02
Filing Date
2024-09-20
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079709_001
    Figure TWG2TA001079709_001
  • Figure TWG2TA001079709_002
    Figure TWG2TA001079709_002
  • Figure TWG2TA001079709_003
    Figure TWG2TA001079709_003
Patent Text Reader

Abstract

Antibodies having highly selective specificity to the human CDH17 protein are identified that are useful for treating cancer. The antibodies can be used to prepare antibody-drug conjugates, which exhibit efficient in vitro and in vivo tumor cell killings.
Need to check novelty before this filing date? Find Prior Art